Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV000411181 | SCV000852172 | pathogenic | Phenylketonuria | 2018-08-05 | reviewed by expert panel | curation | PAH-specific ACMG/AMP criteria applied: PP4: Phe>120 umol/L with PKU (PMID:25456745); PM3: In trans with: c.842+2T>A (P, ClinGen) (PMID:25456745); PS3: 0% in BioPKU; PM2: Extremely low frequency. ExAC MAF=0.00012; PM4: In frame deletion. In summary this variant meets criteria to be classified as pathogenic for phenylketonuria in an autosomal recessive manner based on the ACMG/AMP criteria applied as specified by the PAH Expert Panel: (PP4, PM3, PS3, PM2, PM4). |
Counsyl | RCV000411181 | SCV000485378 | pathogenic | Phenylketonuria | 2015-11-24 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000411181 | SCV000629188 | pathogenic | Phenylketonuria | 2024-11-19 | criteria provided, single submitter | clinical testing | This variant, c.208_210del, results in the deletion of 1 amino acid(s) of the PAH protein (p.Ser70del), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs62642094, gnomAD 0.006%). This variant has been observed in individual(s) with PAH-related diseases from mild hyperphenylalaninemia to classic phenylketonuria (PMID: 15503242, 16256386, 23271928, 23932990; internal data). ClinVar contains an entry for this variant (Variation ID: 102632). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. For these reasons, this variant has been classified as Pathogenic. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000411181 | SCV002015201 | pathogenic | Phenylketonuria | 2021-10-07 | criteria provided, single submitter | clinical testing | Variant summary: PAH c.208_210delTCT (p.Ser70del) results in an in-frame deletion that is predicted to remove one amino acid from the encoded protein that is located in the ACT domain (IPR002912), which proposed to have a regulatory role in protein function (InterPro). The variant allele was found at a frequency of 1.2e-05 in 251342 control chromosomes (gnomAD). c.208_210delTCT has been reported in the literature in several compound heterozygous and homozygous individuals (mostly of East Asian origin) who were affected with Phenylalanine Hydroxylase Deficiency (Phenylketonuria), with reported disease phenotypes ranging from mild hyperphenylalaninemia to classic phenylketonuria (e.g. Okano_1998, Okano_2011, Zhu_2013, Tao_2015, Li_2018, Su_2019, Tao_2021); of note, in the 5 reported homozygous patients a mild PKU phenotype was described (Li_2018, Su_2019). These data indicate that the variant is very likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Four submitters, including an expert panel (ClinGen PAH Variant Curation Expert Panel), have provided clinical-significance assessments for this variant in ClinVar after 2014, and all of them classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. |
Revvity Omics, |
RCV000411181 | SCV002016477 | pathogenic | Phenylketonuria | 2021-07-26 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV000411181 | SCV004209585 | pathogenic | Phenylketonuria | 2023-11-17 | criteria provided, single submitter | clinical testing | |
Juno Genomics, |
RCV000411181 | SCV005416948 | pathogenic | Phenylketonuria | criteria provided, single submitter | clinical testing | PM4+PM3_VeryStrong | |
De |
RCV000088875 | SCV000119469 | not provided | not provided | flagged submission | not provided | ||
De |
RCV000088875 | SCV000119470 | not provided | not provided | flagged submission | not provided | ||
De |
RCV000088875 | SCV000119472 | not provided | not provided | no assertion provided | not provided | ||
Natera, |
RCV000411181 | SCV001455114 | pathogenic | Phenylketonuria | 2020-09-16 | no assertion criteria provided | clinical testing |